388 related articles for article (PubMed ID: 16943582)
21. Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas.
Chile T; Corrêa-Giannella ML; Fortes MA; Bronstein MD; Cunha-Neto MB; Giannella-Neto D; Giorgi RR
J Endocrinol Invest; 2011 Sep; 34(8):e214-8. PubMed ID: 21270509
[TBL] [Abstract][Full Text] [Related]
22. Expression of neuro D1 in human normal pituitaries and pituitary adenomas.
Oyama K; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2001 Sep; 14(9):892-9. PubMed ID: 11557786
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas.
Stilling G; Sun Z; Zhang S; Jin L; Righi A; Kovācs G; Korbonits M; Scheithauer BW; Kovacs K; Lloyd RV
Endocrine; 2010 Aug; 38(1):67-75. PubMed ID: 20960104
[TBL] [Abstract][Full Text] [Related]
24. Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses.
Moreno CS; Evans CO; Zhan X; Okor M; Desiderio DM; Oyesiku NM
Cancer Res; 2005 Nov; 65(22):10214-22. PubMed ID: 16288009
[TBL] [Abstract][Full Text] [Related]
25. A high-throughput analysis of the IDH1(R132H) protein expression in pituitary adenomas.
Casar-Borota O; Øystese KA; Sundström M; Melchior L; Popovic V
Pituitary; 2016 Aug; 19(4):407-14. PubMed ID: 27097804
[TBL] [Abstract][Full Text] [Related]
26. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas.
Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A
Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of microRNAs in GH-secreting pituitary adenomas.
Mao ZG; He DS; Zhou J; Yao B; Xiao WW; Chen CH; Zhu YH; Wang HJ
Diagn Pathol; 2010 Dec; 5():79. PubMed ID: 21138567
[TBL] [Abstract][Full Text] [Related]
28. Wnt4 is overexpressed in human pituitary adenomas and is associated with tumor invasion.
Li W; Zhang Y; Zhang M; Huang G; Zhang Q
J Clin Neurosci; 2014 Jan; 21(1):137-41. PubMed ID: 24200887
[TBL] [Abstract][Full Text] [Related]
29. Expression of FOXL2 in human normal pituitaries and pituitary adenomas.
Egashira N; Takekoshi S; Takei M; Teramoto A; Osamura RY
Mod Pathol; 2011 Jun; 24(6):765-73. PubMed ID: 21478824
[TBL] [Abstract][Full Text] [Related]
30. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas.
Jameson JL; Klibanski A; Black PM; Zervas NT; Lindell CM; Hsu DW; Ridgway EC; Habener JF
J Clin Invest; 1987 Nov; 80(5):1472-8. PubMed ID: 2824561
[TBL] [Abstract][Full Text] [Related]
31. Chromogranin a processing in human pituitary adenomas and carcinomas: analysis with region-specific antibodies.
Jin L; Zhang S; Bayliss J; Scheithauer B; Qian X; Kobayashi I; Stridsberg M; Lloyd RV
Endocr Pathol; 2003; 14(1):37-48. PubMed ID: 12746561
[TBL] [Abstract][Full Text] [Related]
32. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
33. Estrogen receptors in human pituitary tumors.
Burdman JA; Pauni M; Heredia Sereno GM; Bordón AE
Horm Metab Res; 2008 Aug; 40(8):524-7. PubMed ID: 18398784
[TBL] [Abstract][Full Text] [Related]
34. Effects of DNA methylation on galectin-3 expression in pituitary tumors.
Ruebel KH; Jin L; Qian X; Scheithauer BW; Kovacs K; Nakamura N; Zhang H; Raz A; Lloyd RV
Cancer Res; 2005 Feb; 65(4):1136-40. PubMed ID: 15734994
[TBL] [Abstract][Full Text] [Related]
35. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
[TBL] [Abstract][Full Text] [Related]
36. Analysis of IMP3 expression in normal and neoplastic human pituitary tissues.
Righi A; Zhang S; Jin L; Scheithauer BW; Kovacs K; Kovacs G; Goth MI; Korbonits M; Lloyd RV
Endocr Pathol; 2010 Mar; 21(1):25-31. PubMed ID: 19898970
[TBL] [Abstract][Full Text] [Related]
37. Selection and validation of reliable reference genes for RT-qPCR analysis in a large cohort of pituitary adenomas.
Normann KR; Øystese KAB; Berg JP; Lekva T; Berg-Johnsen J; Bollerslev J; Olarescu NC
Mol Cell Endocrinol; 2016 Dec; 437():183-189. PubMed ID: 27561203
[TBL] [Abstract][Full Text] [Related]
38. Survivin products in pituitary tumors.
Jankowska A; Wasko R; Waligorska-Stachura J; Andrusiewicz M; Jaskula M; Liebert W; Sowinski J
Neuro Endocrinol Lett; 2008 Dec; 29(6):1033-7. PubMed ID: 19112393
[TBL] [Abstract][Full Text] [Related]
39. Oncogene-induced senescence in pituitary adenomas and carcinomas.
Alexandraki KI; Munayem Khan M; Chahal HS; Dalantaeva NS; Trivellin G; Berney DM; Caron P; Popovic V; Pfeifer M; Jordan S; Korbonits M; Grossman AB
Hormones (Athens); 2012; 11(3):297-307. PubMed ID: 22908062
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of folate receptor in pituitary adenomas.
Evans CO; Reddy P; Brat DJ; O'Neill EB; Craige B; Stevens VL; Oyesiku NM
Cancer Res; 2003 Jul; 63(14):4218-24. PubMed ID: 12874029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
